Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NFKB1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NFKB1 is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, activates. Associated with ALS, Als, Alzheimer. Connected to 162 entities in the SciDEX knowledge graph.
| Gene Symbol | NFKB1 |
| Full Name | Nuclear Factor Kappa B Subunit 1 |
| Chromosome | 4q24 |
| Protein Family | NF-κB transcription factors |
| Protein Type | Transcription Factor |
| Function | NFKB1 encodes p105, which is processed to p50, a DNA-binding subunit of NF-κB. |
| Molecular Weight | 105 kDa (p105), 50 kDa (p50) |
| Amino Acids | 968 aa |
| Pathways | Nfkb, NFKB, NF-κB, NF-κB pathway |
| UniProt ID | P19838 |
| NCBI Gene ID | 4790 |
| Ensembl ID | ENSG00000109320 |
| OMIM | 164011 |
| GeneCards | NFKB1 |
| Human Protein Atlas | NFKB1 |
| Associated Diseases | ALS, Alzheimer, Alzheimer'S Disease, Cancer, Carcinoma |
| Known Drugs/Compounds | Xiyangshen Sanqi Danshen Granules, Berberine, Electroacupuncture |
| Interactions | IL30, PINK1, APP, PTEN, RELA, BACE1 |
| KG Connections | 420 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
NFKB1["NFKB1"]
NFKB1 -->|"activates"| IL8["IL8"]
NFKB1 -->|"regulates"| CD200R1["CD200R1"]
NFKB1 -->|"regulates"| TNF["TNF"]
NFKB1 -->|"regulates"| IL1B["IL1B"]
NFKB1 -->|"regulates"| microglial_inflammation["microglial inflammation"]
NFKB1 -->|"regulates"| inflammation["inflammation"]
NFKB1 -->|"target for"| Cancer["Cancer"]
NFKB1 -->|"target for"| Als["Als"]
NFKB1 -->|"target for"| Ms["Ms"]
NFKB1 -->|"target for"| Inflammation["Inflammation"]
hyperoxia["hyperoxia"] -->|"activates"| NFKB1
TNF -->|"activates"| NFKB1
TRAF6["TRAF6"] -->|"activates"| NFKB1
DZSM["DZSM"] -->|"regulates"| NFKB1
BCL2["BCL2"] -->|"target for"| NFKB1
MTOR["MTOR"] -->|"target for"| NFKB1
PI3K["PI3K"] -->|"target for"| NFKB1
AKT["AKT"] -->|"target for"| NFKB1
EGFR["EGFR"] -->|"target for"| NFKB1
INFLAMMATION["INFLAMMATION"] -->|"target for"| NFKB1| Target | Relation | Type | Str |
|---|---|---|---|
| SASP | promotes | process | 0.95 |
| C3 | activates | gene | 0.95 |
| Pro-Inflammatory Pathways | activates | pathway | 0.90 |
| Pro-inflammatory Pathways | activates | pathway | 0.90 |
| Dopamine Neuron Survival | inhibits | phenotype | 0.90 |
| NLRP3 | regulates | gene | 0.90 |
| Pro-Inflammatory Cytokines | upregulates | compound | 0.90 |
| IL6 | activates | gene | 0.90 |
| Tnf-Α | upregulates | protein | 0.90 |
| Tnf-Α/Nf-Κb/Mapk Signaling Pathway | involved_in | pathway | 0.90 |
| Inflammation | causes | process | 0.90 |
| Neuroinflammation | activates | process | 0.90 |
| Neuroinflammation | upregulates | process | 0.90 |
| inflammatory activation | mediates | process | 0.87 |
| GFAP | regulates | gene | 0.85 |
| TP53 | regulates | protein | 0.85 |
| Mir125B | activates | biomarker | 0.85 |
| MMP2 | upregulates | protein | 0.85 |
| MMP9 | upregulates | protein | 0.85 |
| inflammatory response | drives | process | 0.85 |
| ALZHEIMER'S DISEASE | biomarker_for | disease | 0.85 |
| PARKINSON'S DISEASE | biomarker_for | disease | 0.85 |
| Neuroinflammation | promotes | process | 0.85 |
| Cytoprotective Proteins | upregulates | process | 0.80 |
| Cytoprotection | involved_in | process | 0.80 |
| Steroid Hormone Effects | involved_in | mechanism | 0.80 |
| Cognitive Function | involved_in | phenotype | 0.80 |
| lipid metabolism dysregulation | drives | process | 0.80 |
| Cognitive Protection | involved_in | process | 0.80 |
| IL8 | activates | gene | 0.80 |
| Alzheimer's Disease | contributes_to | disease | 0.80 |
| Alzheimer's Disease | activates | disease | 0.80 |
| NF-kB signaling | participates_in | pathway | 0.80 |
| Inflammation | promotes | process | 0.80 |
| Alzheimer'S Disease | associated_with | disease | 0.80 |
| Lipid Metabolism | regulates | process | 0.80 |
| Cognitive Impairment Protection | mediates | mechanism | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| TNF | regulates | protein | 0.70 |
| IL1B | regulates | protein | 0.70 |
| microglial inflammation | regulates | process | 0.70 |
| KCNK2 | interacts_with | gene | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| inflammation | regulates | process | 0.70 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Berberine | inhibits | compound | 0.95 |
| Nfkbia | inhibits | protein | 0.95 |
| MYDD88 | activates | protein | 0.90 |
| HVCN1 | activates | gene | 0.90 |
| TGM2 | drives | protein | 0.90 |
| Electroacupuncture | inhibits | drug | 0.90 |
| IKBA | suppresses | protein | 0.90 |
| h-646ae8f1 | targets_gene | hypothesis | 0.90 |
| ROS overproduction | activates | process | 0.88 |
| TLR4 | activates | protein | 0.85 |
| Tg2-In1 | suppresses | drug | 0.85 |
| Theranekron | downregulates | drug | 0.85 |
| AMPK | inhibits | protein | 0.85 |
| hyperoxia | activates | phenotype | 0.80 |
| Xiyangshen Sanqi Danshen Granules | inhibits | drug | 0.80 |
| SIRT1 | inhibits | protein | 0.80 |
| APP | activates | gene | 0.80 |
| TNF | activates | protein | 0.70 |
| TRAF6 | activates | protein | 0.70 |
| DZSM | regulates | drug | 0.70 |
| PI3K | therapeutic_target | gene | 0.70 |
| EGFR | therapeutic_target | gene | 0.70 |
| CASP3 | therapeutic_target | gene | 0.70 |
| LRRK2 | co_discussed | gene | 0.65 |
| PINK1 | phosphorylates | gene | 0.65 |
| BCL2 | therapeutic_target | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| FASN | activates | gene | 0.60 |
| NFKBIA | activates | gene | 0.60 |
| PGC1A | activates | gene | 0.60 |
| PER2 | expressed_in | gene | 0.60 |
| LPL | activates | gene | 0.60 |
| CLOCK | activates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| PPARG | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| NR1D1 | expressed_in | gene | 0.60 |
| RELA | expressed_in | gene | 0.60 |
| MYC | expressed_in | gene | 0.60 |
| SP1 | expressed_in | gene | 0.60 |
| IRF7 | expressed_in | gene | 0.60 |
| PPARGC1A | expressed_in | gene | 0.60 |
| ATF4 | expressed_in | gene | 0.60 |
| JUN | expressed_in | gene | 0.60 |
| BCL2 | activates | gene | 0.60 |
| ANG | activates | gene | 0.60 |
| PDGFRB | activates | gene | 0.60 |
| ATF3 | inhibits | gene | 0.60 |
| EGR1 | protects_against | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 14 hypotheses Top: 0.508
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||